We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA批准了Idvynso(doravirine/islatravir)——首个不含整合酶抑制剂和替诺福韦的两药方案。了解为什么这成为老年HIV患者的新治疗标准。阅读详情。
EMA验证了儿科Dovato(多替拉韦/拉米夫定)用于2岁以上儿童的申请。了解双药疗法如何改变HIV治疗标准。